Detalhe da pesquisa
1.
SHON expression predicts response and relapse risk of breast cancer patients after anthracycline-based combination chemotherapy or tamoxifen treatment.
Br J Cancer
; 120(7): 728-745, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30816325
2.
ERCC1-XPF deficiency is a predictor of olaparib induced synthetic lethality and platinum sensitivity in epithelial ovarian cancers.
Gynecol Oncol
; 153(2): 416-424, 2019 05.
Artigo
Inglês
| MEDLINE | ID: mdl-30797591
3.
Targeting ataxia telangiectasia-mutated- and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized therapy.
Breast Cancer Res Treat
; 169(2): 277-286, 2018 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-29396668
4.
SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis.
Lancet Oncol
; 17(7): 1004-1018, 2016 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-27312051
5.
Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers.
Carcinogenesis
; 37(1): 63-71, 2016 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26586793
6.
Untangling the clinicopathological significance of MRE11-RAD50-NBS1 complex in sporadic breast cancers.
NPJ Breast Cancer
; 7(1): 143, 2021 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34782604
7.
SPAG5: An Emerging Oncogene.
Trends Cancer
; 6(7): 543-547, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32291236
8.
Association of Sperm-Associated Antigen 5 and Treatment Response in Patients With Estrogen Receptor-Positive Breast Cancer.
JAMA Netw Open
; 3(7): e209486, 2020 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32633764
9.
ERCC1 Is a Predictor of Anthracycline Resistance and Taxane Sensitivity in Early Stage or Locally Advanced Breast Cancers.
Cancers (Basel)
; 11(8)2019 Aug 10.
Artigo
Inglês
| MEDLINE | ID: mdl-31405143
10.
Immune-Phenotyping and Transcriptomic Profiling of Peripheral Blood Mononuclear Cells From Patients With Breast Cancer: Identification of a 3 Gene Signature Which Predicts Relapse of Triple Negative Breast Cancer.
Front Immunol
; 9: 2028, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30254632
11.
Evaluation of CDK12 Protein Expression as a Potential Novel Biomarker for DNA Damage Response-Targeted Therapies in Breast Cancer.
Mol Cancer Ther
; 17(1): 306-315, 2018 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29133620
12.
The localization of pre mRNA splicing factor PRPF38B is a novel prognostic biomarker that may predict survival benefit of trastuzumab in patients with breast cancer overexpressing HER2.
Oncotarget
; 8(68): 112245-112257, 2017 Dec 22.
Artigo
Inglês
| MEDLINE | ID: mdl-29348822
13.
HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression Analysis.
Clin Cancer Res
; 22(4): 905-14, 2016 Feb 15.
Artigo
Inglês
| MEDLINE | ID: mdl-26240276
14.
Chk1 phosphorylated at serine345 is a predictor of early local recurrence and radio-resistance in breast cancer.
Mol Oncol
; 10(2): 213-23, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26459098
15.
DNA repair prognostic index modelling reveals an essential role for base excision repair in influencing clinical outcomes in ER negative and triple negative breast cancers.
Oncotarget
; 6(26): 21964-78, 2015 Sep 08.
Artigo
Inglês
| MEDLINE | ID: mdl-26267318
16.
Nottingham Clinico-Pathological Response Index (NPRI) after neoadjuvant chemotherapy (Neo-ACT) accurately predicts clinical outcome in locally advanced breast cancer.
Clin Cancer Res
; 21(5): 1052-62, 2015 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25520390
17.
Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast Cancer.
Mol Cancer Ther
; 14(4): 1057-65, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25673821
18.
Is there a role for base excision repair in estrogen/estrogen receptor-driven breast cancers?
Antioxid Redox Signal
; 21(16): 2262-8, 2014 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25111287
19.
Clinicopathological significance of ATM-Chk2 expression in sporadic breast cancers: a comprehensive analysis in large cohorts.
Neoplasia
; 16(11): 982-91, 2014 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-25425972
20.
SHON is a novel estrogen-regulated oncogene in mammary carcinoma that predicts patient response to endocrine therapy.
Cancer Res
; 73(23): 6951-62, 2013 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-24296488